Lancet Infect Dis. 2016 Apr;16(4):421-30.doi: 10.1016/S1473-3099(16)00017-7. Epub 2016 Feb 5.
Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL)